| Absorption |
| Blood-Brain Barrier | BBB- | 0.9488 |
| Human Intestinal Absorption | HIA+ | 0.9956 |
| Caco-2 Permeability | Caco2- | 0.5564 |
| P-glycoprotein Substrate | Substrate | 0.5499 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.8820 |
| Non-inhibitor | 0.9620 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.9379 |
| Distribution |
| Subcellular localization | Mitochondria | 0.7075 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8052 |
| CYP450 2D6 Substrate | Non-substrate | 0.5843 |
| CYP450 3A4 Substrate | Non-substrate | 0.5841 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.7285 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.8126 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.7513 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.8375 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.8819 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.7781 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9676 |
| Non-inhibitor | 0.7683 |
| AMES Toxicity | Non AMES toxic | 0.7703 |
| Carcinogens | Non-carcinogens | 0.8754 |
| Fish Toxicity | High FHMT | 0.8248 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9974 |
| Honey Bee Toxicity | Low HBT | 0.5000 |
| Biodegradation | Not ready biodegradable | 0.9363 |
| Acute Oral Toxicity | III | 0.7434 |
| Carcinogenicity (Three-class) | Non-required | 0.6694 |